02.22.20 -- 'Genetic Rewiring' By microRNA Gene Drives Cancer's Drug Resistance

This application note proposes an alternate but equally effective approach to biosimilar purification, by substituting a less expensive ion exchange resin for the affinity capture step.

To address the ongoing public health crisis related to opioid abuse, Xtampza ER has been developed to resist the ability of abusers to tamper with the product and alter the route of administration.

Time to experiment, time to clinic, and time to market is becoming even more important for developers and manufacturers of biopharmaceuticals. At the same time, the amount of data enclosed in biologic license applications are more comprehensive to avoid extended review. In this webinar we will review three fields that enable reduced timelines and improved outcomes of process development activities.

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.